Literature DB >> 23217595

Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database.

Yi-Der Jiang1, Chia-Hsuin Chang, Tong-Yuan Tai, Jung-Fu Chen, Lee-Ming Chuang.   

Abstract

BACKGROUND/
PURPOSE: Formerly, Taiwan's diabetic population has been estimated by surveys conducted at irregular intervals and using different sampling methods. To obtain nationwide data on the incidence and prevalence of diabetes mellitus (DM) in Taiwan, we performed an analysis of the 2000-2009 claim data from the National Health Insurance (NHI) database.
METHODS: One-third of the claims in the NHI database from 2000 to 2009 were randomly sampled. DM was defined by three or more outpatient visits with diagnostic codes (ICD-9-CM: 250 or A code: A181) within 1 year or by one inpatient discharge diagnosis of DM. Confirmation of type 1 diabetes mellitus was based on the issue of a catastrophic illness certificate with the same diagnostic codes. Age and/or gender distribution for DM were determined.
RESULTS: In accordance with the global trend for DM, with a near constant standardized incidence rate, there was a more than 70% increase in the total diabetic population, or a 35% increase in the standardized prevalence rate, in Taiwan from 2000 to 2009. The incidence of diabetes was higher in men, especially in the 20-59-year-old age group, and the total number of men with diabetes exceeded the number of women with diabetes in 2005. However, the prevalence and incidence rates in women over the age of 60 years were higher than those in men. Type 1 DM was present in less than 1% of the diabetic population in Taiwan.
CONCLUSION: The incidence of diabetes, including type 1, remained stable over this 10-year period in Taiwan. However, the incidence rate in men aged 20-59 years was higher than that in age-matched women. With our nationwide database, subgroup analysis of DM incidence can be performed to refine our health policies for the prevention, screening, and treatment of diabetes mellitus.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 23217595     DOI: 10.1016/j.jfma.2012.09.014

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  68 in total

1.  Characteristics and Risk Factors for Fatality in Patients with Dengue Hemorrhagic Fever, Taiwan, 2014.

Authors:  Hsin-Yi Wei; Pei-Yun Shu; Min-Nan Hung
Journal:  Am J Trop Med Hyg       Date:  2016-06-06       Impact factor: 2.345

2.  Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up.

Authors:  Hsuan-Ying Chen; Shihchen Kuo; Pei-Fang Su; Jin-Shang Wu; Huang-Tz Ou
Journal:  Diabetes Care       Date:  2020-05-22       Impact factor: 19.112

3.  Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome - Data from Taiwan's Acute Coronary Syndrome Full Spectrum Data Registry.

Authors:  Cheng-Chun Wei; Kou-Gi Shyu; Jun-Jack Cheng; Hei-Ming Lo; Chiung-Zuan Chiu
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

4.  The growing prevalence of type 2 diabetes: increased incidence or improved survival?

Authors:  Nisa M Maruthur
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

5.  Ankylosing spondylitis and other inflammatory spondyloarthritis increase the risk of developing type 2 diabetes in an Asian population.

Authors:  Hsin-Hung Chen; Su-Yin Yeh; Hue-Yong Chen; Cheng-Li Lin; Fung-Chang Sung; Chia-Hung Kao
Journal:  Rheumatol Int       Date:  2013-12-22       Impact factor: 2.631

6.  Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: A population-based cohort followed over 10 years.

Authors:  Tsung-Ying Lee; Shihchen Kuo; Chen-Yi Yang; Huang-Tz Ou
Journal:  Br J Clin Pharmacol       Date:  2020-01-23       Impact factor: 4.335

7.  Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial.

Authors:  Jyun-Hong Chen; Huang-Tz Ou; Tzu-Chieh Lin; Edward Chia-Cheng Lai; Yea-Huei Yang Kao
Journal:  Int J Clin Pharm       Date:  2016-02

8.  The relationships between thyroid-stimulating hormone level and insulin resistance, glucose effectiveness, first- and second-phase insulin secretion in Chinese populations.

Authors:  Tsung-Ju Chuang; Jiunn-Diann Lin; Chung-Ze Wu; Hui-Chun Ku; Chun-Cheng Liao; Chih-Jung Yeh; Dee Pei; Yen-Lin Chen
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

9.  Association between selective serotonin reuptake inhibitor and risk of peripheral artery disease in diabetes mellitus: Propensity score matching and landmark analysis.

Authors:  Kai-Hua Chen; Ting-Yao Wang; Chuan-Pin Lee; Yao-Hsu Yang; Roger S McIntyre; Mehala Subramaniapillai; Yena Lee; Vincent Chin-Hung Chen
Journal:  Medicine (Baltimore)       Date:  2022-05-06       Impact factor: 1.817

10.  Risk factors for invasive Cryptococcus neoformans diseases: a case-control study.

Authors:  Ying-Ying Lin; Stephanie Shiau; Chi-Tai Fang
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.